DEC 06, 2017 09:33 AM PST

Mutations in the Immune System Increase Risk of Hodgkin Lymphoma

WRITTEN BY: Kara Marker

A first-of-its-kind study reveals genetic variants in the immune system that increase the risk of Hodgkin lymphoma, a type of cancer that commonly affects young adults. From the Institute of Cancer research, scientists pave the way for potential new treatments based on these genetic changes.

Histopathologic image of Hodgkin's lymphoma, lymph node biopsy. Credit: Wikimedia user KGH

Hodgkin lymphoma is a cancer defined by the abnormal growth and proliferation of lymphocytes, These are immune cells such as B cells and T cells, with the cancer usually beginning in B cells, which produce antibodies. First-line therapies successfully clear out cancer for most patients, but for those that need more, these new findings might be helpful. About 80 percent of people who develop Hodgkin lymphoma survive in the long-term, but sometimes treatment for this type of cancer results in long-term effects; new and better treatments could make survival rates even higher and lower the prevalence of long-term side effects.

In the new study, researchers completed an analysis of genetic data from 5,314 cases of Hodgkin lymphoma and 16,749 controls. They identified six genetic variations with just one letter change, meaning the A, G, T, and C nucleotides that make up DNA. Five of these changes impact the way B cells develop and increase the risk of lymphoma by 15 to 30 percent. Three have already been associated with autoimmune diseases like multiple sclerosis, rheumatoid arthritis, and lupus in the past.

"It doesn't mean that if you develop an autoimmune disease you are at increased risk of lymphoma, but it does offer fascinating genetic clues to these diseases,” explained Richard Houlston. “The new information could point towards new ways of diagnosing, treating, or even helping to prevent Hodgkin lymphoma."

The study’s results also indicated that different genetic variants are associated with risk of different types of Hodgkin lymphoma, such as nodular sclerosis Hodgkin lymphoma and mixed cellularity Hodgkin lymphoma.

"Understanding the genetic changes that underpin cancer's development is crucial for all aspects of our quest to defeat cancer,” explained Paul Workman. “To understand which patients are most at risk from different types of cancer, to improve diagnosis, and to develop treatments that are most likely to work for individual patients.”

The present study is published in the journal Nature Communications.

Sources: American Cancer Society, Institute of Cancer Research

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
PARP Inhibitors Boost Immune Efficacy
In a recent research study, precision cancer drugs called PARP inhibitors are previously known to boost the immune system were found to spark a powerful im...
NOV 17, 2019
Health & Medicine
NOV 17, 2019
Tick-Borne Diseases Are Rapidly Rising in the U.S.
Tick-borne diseases have significantly increased in the U.S. in the past few years. In 2016 there were 48,610 reported cases and in 2017 59,349; these...
NOV 17, 2019
Immunology
NOV 17, 2019
The C-word. Michael Kinch's new book and the future of Cancer Treatment
The C-word. Dare we say it? Is a cure for cancer within reach?   Professor Michael Kinch https://publichealth.wustl.edu/scholars/michael-s-kinch/ of W...
NOV 17, 2019
Microbiology
NOV 17, 2019
Gut Microbes may Link Stress and Autoimmune Disease
Stress can have a detrimental effect on our health, and appears to contribute to the development of autoimmune diseases....
NOV 17, 2019
Infographics
NOV 17, 2019
Surface Plasmon Resonance (SPR) Technology
Surface plasmon resonance (SPR) allows researchers to investigate different types of biomolecular interactions and mechanisms in real-time and label-free....
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
Effective Vaccines for Lyme Disease?
Currently, there are no effective vaccines available for the presentation of Lyme disease. The only preventive efforts present includes “guiding&rdqu...
Loading Comments...